iqirvo - elafibranor tablet, film coated
(Elafibranor)Ipsen Biopharmaceuticals, Inc.
Usage: IQIRVO treats primary biliary cholangitis (PBC) in adults with inadequate response to ursodeoxycholic acid (UDCA), used in combination with UDCA or as monotherapy when UDCA cannot be tolerated. Approved under accelerated approval based on reduction of alkaline phosphatase.